Prostate cancer decisions — 2026

Service connection for hypertension and prostate cancer is granted under the PACT Act. Service connection for stroke is remanded.,The Veteran's hypertension and prostate cancer are presumed due to exposure to herbicide agents during service, while his stroke claim requires further examination and opinion.

The Veteran requested to withdraw his appeal for reducing the disability rating from 100% to 40% for prostate cancer. The Board dismissed the appeal as a result.

The Board has remanded the case for further adjudication due to insufficient evidence regarding whether a prostate condition, including benign hyperplasia and cancer, is secondary to type II diabetes mellitus. The issue of an earlier effective date for service connection for prostate cancer remains unresolved as well.

The Veteran's prostate cancer is remanded for further development to consider potential exposure to toxins and other chemicals during his service at Plattsburgh Air Force Base, as well as any potential exposure to ionizing radiation from live nuclear weapons. The AOJ will also verify the Veteran's claimed period of active duty in the neutral zone between Iraq and Saudi Arabia.

The Veteran's appeal for a higher initial rating for prostate cancer is dismissed as it is considered a prohibited concurrent appeal with another issue already adjudicated by the Board.

The Veteran's claims for service connection were denied for central renal vein occlusion of the right eye, hernia, paroxysmal supraventricular tachycardia (PSVT), and prostate cancer. The Board found no evidence linking these conditions to service or service-connected disabilities.

The Veteran's claims for earlier effective dates for prostate cancer and erectile dysfunction have been dismissed as the appeal was erroneously docketed at the Board.

The Board has decided to remand the claim for service connection for residuals of prostate cancer due to errors in obtaining necessary medical opinions and verifying the Veteran's periods of active duty.

The Veteran's initial rating for urinary incontinence, neoplasm including prostate cancer, remission is granted at a 20 percent level. The Veteran's service-connected erectile dysfunction associated with his urinary issues is not rated compensably.

The Veteran's claim for compensation under 38 U.S.C. § 1151 is remanded due to the need for additional development, including obtaining consent forms and operation reports related to his February 2011 prostatectomy, and providing an opinion on whether the surgery caused or aggravated his existing erectile dysfunction.

The Veteran's neoplasms of the male reproductive system, including prostate cancer are in remission and do not meet the criteria for a compensable disability rating.,Degenerative arthritis of the lumbar spine does not meet the criteria for an initial rating in excess of 10 percent during the period on appeal.,The effective date for SMC based on loss of use of a creative organ is August 10, 2023.

The Veteran's service connection claim for residuals of prostate cancer is granted as there is a medical nexus between an in-service incurrence and the current diagnosis.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) prior to May 17, 2017 and his claim for special monthly compensation (SMC) based on statutory housebound criteria prior to that date. The decision is final as it does not address service connection.

The Veteran's prostate cancer residuals have led to a need for regular aid and attendance, resulting in the grant of SMC. Service connection for ALS was also granted.

The Board denied the Veteran's claim for service connection for prostate cancer as there was no evidence of in-service exposure to herbicide agents or a link between his current condition and his military service.

The Veteran's service-connected prostate cancer and insomnia have rendered him unable to perform daily activities of living without the assistance of another, warranting SMC for aid and attendance.

The Veteran's depressive disorder is rated at 50 percent, but the Board found that his symptoms did not meet the criteria for a higher rating. The Veteran does not have current diagnoses of allergic rhinitis, headaches, gastroesophageal reflux disease (GERD), or prostate cancer.

The Board denied service connection for ischemic heart disease, prostate cancer, and erectile dysfunction due to herbicide exposure. The claims were remanded multiple times but the evidence did not support the Veteran's claim of exposure.

The Board denied service connection for heart disability and prostate cancer, both claimed as due to herbicide exposure in Korea. The evidence did not establish the Veteran's exposure to herbicides during service.

The Veteran's diagnosed hypertension, sinusitis, and prostate cancer are etiologically related to his presumed in-service Agent Orange exposure. Service connection is granted for these conditions.